Presents an analysis of the predictive relevance of the expression of the bcl-2 gene encoding a mitochondrial protein thought to prevent apoptosis of normal cells, on six-year relapse-free and survival in lymph node-negative breast cancers in relation to pathologic and biologic p53 protein expression. Bcl-2 immunoreactivity; Expression; Clinical outcome.